This study enrolls people who have participated in the preceding study, TrialNet Pathway to Prevention Study. The purpose of this study is to find out whether treatment of participants at Stage 1 Type 1 Diabetes with hydroxychloroquine delays progression to Stage 2 and Stage 3 Type 1 Diabetes. Please contact us to learn more about this research study. Read More
Children ages 3+ and adults.
Must have participated in preceding study (potential study participants will be identified through the ongoing TrialNet Pathway to Prevention Study).